04:57 PM EST, 03/05/2024 (MT Newswires) -- Orthofix Medical ( OFIX ) reported a Q4 loss late Tuesday of $0.59 per diluted share, wider than a loss of $0.35 a year earlier.

Four analysts surveyed by Capital IQ expected a loss of $0.49.

Net sales for the quarter ended Dec. 31 were $200.4 million, up from $122.2 million a year earlier.

Four analysts surveyed by Capital IQ expected $195.6 million.

The company said it expects full-year 2024 net sales of $785 million to $795 million. Analysts surveyed by Capital IQ expect $798.6 million.

Shares of the company fell 1.9% in after-hours trading.

Price: 12.75, Change: -0.25, Percent Change: -1.92